Dr. Larissa Derzko-Dzulynsky
Participates in 4 items
Dr. Derzko-Dzulynsky completed her undergraduate and medical degrees at the University of Toronto, followed by fellowship training in uveitis at McGill University and post-fellowship training in retina and uveitis at the U of T Department of Ophthalmology and Vision Sciences (DOVS). Dr. Derzko-Dzulynsky was appointed Lecturer in the DOVS in 2000, promoted to Assistant Professor in 2008 then to her current position as Chief of the Uveitis Service in 2013. In addition, she is on staff at St. Joseph’s Health Centre, Kensington Eye Institute and St. Michael’s Hospital.
Dr. Derzko-Dzulynsky actively participates in resident clinical and surgical teaching in the DOVS. Research activities have included a resident-led quality-improvement project on wait times for uveitis consults in Toronto, and a study on clinical features of infectious posterior uveitis at St. Michael’s Hospital. She recently published on cataract surgery outcomes in uveitis and IgG4 panuveitis. Dr. Derzko-Dzulynsky is primary investigator on a resident-led multidisciplinary and translational research project on PCR utilization in anterior uveitis cases, which was awarded a grant from the DOVS Pilot Research Grant Competition in December 2016.
Dr. Derzko-Dzulynsky participated on an Ontario Task Force for Uveitis Care that established standardized criteria for immunomodulatory treatment for uveitis (MOHTLC Exceptional Access Program) and developed a standardized communication tool for use between ophthalmologists and rheumatologists. This tool will be used for a new Uveitis Registry in Ontario, which Dr. Derzko-Dzulynsky will be launching with the Task Force for Uveitis Care. She was President of the Canadian Uveitis Society from 2010-2013, during which time she worked closely with the Canadian Ophthalmological Society and the Ontario Rheumatology Association to increase awareness of uveitis at the provincial and federal government levels. She has also been the Canadian representative at the International Ocular Inflammation Society since 2013.
Dr. Derzko-Dzulynsky enjoys various sports and outdoor activities including cycling and skiing, as well as spending time with her family. She has raised funds for The Foundation Fighting Blindness through her participation in Cycle for Sight.
Financial disclosure: I have/had an affiliation (financial or otherwise) with a commercial organization:
1. Abbvie
2. Amgen
3. Gilead
4. Santen, Inc.
Dr. Derzko-Dzulynsky actively participates in resident clinical and surgical teaching in the DOVS. Research activities have included a resident-led quality-improvement project on wait times for uveitis consults in Toronto, and a study on clinical features of infectious posterior uveitis at St. Michael’s Hospital. She recently published on cataract surgery outcomes in uveitis and IgG4 panuveitis. Dr. Derzko-Dzulynsky is primary investigator on a resident-led multidisciplinary and translational research project on PCR utilization in anterior uveitis cases, which was awarded a grant from the DOVS Pilot Research Grant Competition in December 2016.
Dr. Derzko-Dzulynsky participated on an Ontario Task Force for Uveitis Care that established standardized criteria for immunomodulatory treatment for uveitis (MOHTLC Exceptional Access Program) and developed a standardized communication tool for use between ophthalmologists and rheumatologists. This tool will be used for a new Uveitis Registry in Ontario, which Dr. Derzko-Dzulynsky will be launching with the Task Force for Uveitis Care. She was President of the Canadian Uveitis Society from 2010-2013, during which time she worked closely with the Canadian Ophthalmological Society and the Ontario Rheumatology Association to increase awareness of uveitis at the provincial and federal government levels. She has also been the Canadian representative at the International Ocular Inflammation Society since 2013.
Dr. Derzko-Dzulynsky enjoys various sports and outdoor activities including cycling and skiing, as well as spending time with her family. She has raised funds for The Foundation Fighting Blindness through her participation in Cycle for Sight.
Financial disclosure: I have/had an affiliation (financial or otherwise) with a commercial organization:
1. Abbvie
2. Amgen
3. Gilead
4. Santen, Inc.
Sessions in which Dr. Larissa Derzko-Dzulynsky participates
1:35 PM
1:35 PM
- General ophthalmology and uveitis
- Participant Dr. Larissa Derzko-Dzulynsky | Participant John Lloyd MD | Participant Dr. Amandeep Rai, MD, FRCSC | Participant Chryssa McAlister |
- 1:35 PM - 2:30 PM | 55 minutes Part of: Toronto Eye Review Course: Practical pearls for everyday practice
6:30 AM
6:30 AM
- Non-Infectious Uveitis: What's best for my patient: Local or systemic treatment? Metro Toronto Convention Centre (South Building) - Room 803
- 6:30 AM - 8:00 AM | 1 hour 30 minutes
- LEARNING OBJECTIVES:At the end of this symposium, participants will be able to:Describe the advantages and limitations o...
- Panel | Table ronde
7:20 AM
7:20 AM
- Immunosuppression for uveitis: What, when, how, and by whom?
- Participant Dr. Larissa Derzko-Dzulynsky |
- 7:20 AM - 7:33 AM | 13 minutes Part of: Non-Infectious Uveitis: What's best for my patient: Local or systemic treatment?
- Talk | Exposé
7:50 AM
7:50 AM
- Discussion panel
- Moderator Dr. Éric Fortin (University of Montreal clinical center at Maisonneuve-Rosemont hospital) | Participant Amin Kherani MD, FRCSC | Participant Dr. Chloe Gottlieb, MD, FRCSC (University of Ottawa Eye Institute) | Participant Marc de Smet MDCM, PhD, FRCSC | Participant Dr. Larissa Derzko-Dzulynsky | Participant Olga Ziouzina MD |
- 7:50 AM - 8:00 AM | 10 minutes Part of: Non-Infectious Uveitis: What's best for my patient: Local or systemic treatment?
- Panel | Table ronde